GENZYME ACQUISITION OF BIOSURFACE TECHNOLOGY, INC.
Executive Summary
GENZYME ACQUISITION OF BIOSURFACE TECHNOLOGY, INC. will create a tissue repair business within Genzyme having a $20 mil. R&D budget in its first year. The combination of the two firms' tissue repair portfolios will give Genzyme "the most comprehensive technology base" in the field, the company maintained July 26.